NCT06035718

Brief Summary

The aim of the current study is to investigate and compare the effectiveness of probiotic supplementation and tDCS stimulation on risky decision-making related to food choices in overweight people. Considering the relatively established communication and interaction between the gut-brain-microbiome axis, the investigators expect that transcranial direct current stimulation and probiotic supplementation can both improve decision-making (decrease risky and impulsive decisions) and increase self-control in overweight people.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

1.3 years

First QC Date

September 6, 2023

Last Update Submit

November 27, 2023

Conditions

Keywords

transcranial direct current stimulationobesityoverweightimpulse control

Outcome Measures

Primary Outcomes (5)

  • Body analysis test

    This is a technique to determine the percentage of body mass that is fat compared to muscle. It can also indicate where the fat and muscle are carried within the body.

    Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.

  • Impulsive Behavior Scale Questionnaire measuring Urgency, Premeditation (lack of), Perseverance (lack of), and Sensation seeking (UPPS)

    This is a self-report tool that assesses five subscales (urgency, premeditation, perseverance, sensation seeking, and positive urgency) that are used to measure five distinct dimensions of impulsive behavior; each scale ranging from 4 to 16); Higher scores represent worse outcome.

    Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.

  • Eating attitudes Test (EAT-26)

    This tool is used to identify the presence of "eating disorder risk" based on attitudes, feelings and behaviours related to eating. The total score (between 0 and 78) provides an overall risk score, where higher scores indicating greater risk of an eating disorder.

    Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.

  • Balloon analogue risk task (BART)

    BART is a computerized decision-making task that is used to assess risk-taking behavior. The BART simulates a real-world situation, involving actual risky behavior, where taking a risk up until a certain point yields a reward.

    Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.

  • Tangney self-control questionnaire (Form 36)

    This is a self-report measurement to assess individual differences in traits of self-control. Scores range from 0 to 144 with higher scores representing worse outcome.

    Depending on the experimental group: 10 stimulation days in tDCS groups and 30 days in the probiotic group.

Study Arms (4)

Active tDCS over the dorsolateral prefrontal cortex (DLPFC)

EXPERIMENTAL

In this group, participants will receive active 2 milliampere (mA) tdcs over the DLPFC (anode on F3 and cathode onF4) for 20 minutes.

Device: tDCS

Active tDCS over the ventromedial prefrontal cortex (VMPFC)

ACTIVE COMPARATOR

In this group, participants will receive active 2 mA tdcs over the VMPFC (anode on Fpz and cathode on Cz) for 20 minutes.

Device: tDCS

Sham tDCS Stimulation

SHAM COMPARATOR

In this group, participants will receive sham tDCS which will ramp up for 30 s at the beginning of the session and then ramp down and be switched off during the 20-minute stimulation session.

Device: Sham tDCS

Probiotic supplementation

ACTIVE COMPARATOR

In this group, participants will consume 2 probiotic supplements (The synbiotics family) daily, for one month.

Drug: Probiotic Blend Capsule

Interventions

By a probiotic blend capsule a specific product is intended which contains the following: Lactobacillus rhamnosus Lactobacillus plantarum Lactobacillus casei Lactobacillus helveticus Lactobacillus acidophilus Lactobacillus bulgaricus Lactobacillus gasseri Bifidobacterium bifidum Bifidobacterium lactis Bifidobacterium breve Bifidobacterium longum Streptococcus thermophile Fructooligosaccharides (FOS).

Probiotic supplementation
tDCSDEVICE

Using a tDCS device, a mild direct electric current is going to be non-invasively administered to the brain using rubber electrodes placed over the scalp.

Active tDCS over the dorsolateral prefrontal cortex (DLPFC)Active tDCS over the ventromedial prefrontal cortex (VMPFC)
Sham tDCSDEVICE

Using a tDCS device, a mild direct electric current is going to be non-invasively administered to the brain using rubber electrodes placed over the scalp. At this arm the electric current will be applied for a very short time (30 s) after which the device will turn off, thus providing the initial tingling sensation over the scalp but not interfering with the ongoing brain activity.

Sham tDCS Stimulation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI over 25
  • Higher than normal fat level

You may not qualify if:

  • Pregnancy
  • Breastfeeding
  • Smoking more than 10 cigarettes a day
  • Excessive consumption of alcohol
  • Suffering from chronic cardiovascular and kidney diseases
  • Chronic digestive diseases such as celiac disease,
  • Chronic inflammatory bowel diseases such as colitis, intestinal surgery, cancer, etc.
  • Suffering from acute and chronic diarrhea in the last one month
  • Taking antibiotics in two months before the start of the study,
  • Continuous use of prebiotic and probiotic products and drugs in one month before the start of the intervention
  • Frequent use of antibiotics during the last month before the start of the intervention
  • Taking weight loss medications and following a special slimming diet in the last 3 months before the intervention.
  • History of epilepsy and seizures, stroke,
  • Use of pacemaker
  • Presence of metal implanted in the scalp or brain,
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atieh neuroscience center

Tehran, 1969713663, Iran

RECRUITING

MeSH Terms

Conditions

OverweightObesity

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Marzieh Heysiattalab, PhD

    University of Tabriz

    STUDY DIRECTOR
  • Reza Kazemi, PhD

    University of Tehran

    STUDY DIRECTOR
  • Sara Derafsheh, MSC

    University of Tabriz

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abed Hadipour Lakmehsari, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

September 6, 2023

First Posted

September 13, 2023

Study Start

March 1, 2023

Primary Completion

July 1, 2024

Study Completion

September 1, 2024

Last Updated

November 28, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations